STRO

Sutro Biopharma

• NASDAQ·2d ago

  RLAY Hits 52-Week High, MPLT Nears Lockup Expiry; ORKA Makes EVERLASTing Gains

• TipRanks·4d ago

  Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s

• TipRanks·4d ago

  Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls

• Dow Jones·4d ago

  Sutro Biopharma Price Target Announced at $38.00/Share by Leerink Partners

• TipRanks·4d ago

  Sutro Biopharma initiated with an Outperform at Leerink

• Reuters·4d ago

  SUTRO BIOPHARMA INC <STRO.O>: LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $38

• Reuters·5d ago

  U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO

• Benzinga·04/01 21:32

  Sutro Biopharma Enters Sales Agreement With TD Securities; Co. May Offer & Sell Shares Of Common Stock Of Up To $100M

• Reuters·04/01 21:23

  SUTRO BIOPHARMA: ENTERS SALES AGREEMENT, MAY OFFER & SELL SHARES OF COMMON STOCK OF UP TO $100 MLN - SEC FILING

• NASDAQ·04/01 07:19

  Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?

• Dow Jones·03/25 16:53

  Sutro Biopharma Is Maintained at Buy by Deutsche Bank

• Benzinga·03/25 16:43

  Deutsche Bank Maintains Buy on Sutro Biopharma, Raises Price Target to $55

• TipRanks·03/25 12:51

  Sutro Biopharma price target raised to $55 from $51 at Deutsche Bank

• Reuters·03/25 11:05

  SUTRO BIOPHARMA INC. <STRO.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $55 FROM $51

• Reuters·03/25 08:01

  U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources